Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- Check3 days agoChange DetectedUpdated to v3.0.2 and added a MedlinePlus Genetics topic on Rheumatoid arthritis; removed the Back to Top navigation.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated to include a new research article on the safety profile of Upadacitinib, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new MedlinePlus related topics on arthritis. Some previous entries have been removed, particularly related to location names and certain medical topics.SummaryDifference15%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.0%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.